Artificial Intelligence and Machine Learning in Drug Discovery
Author:
Publisher
Springer Nature Singapore
Link
https://link.springer.com/content/pdf/10.1007/978-981-99-1316-9_9
Reference42 articles.
1. Abedi V, Goyal N, Tsivgoulis G et al (2017) Novel screening tool for stroke using artificial neural network. Stroke 48(6):1678–1681. https://doi.org/10.1161/STROKEAHA.117.017033
2. Ballester PJ, Mitchell JBO (2012) A machine learning approach to predicting protein-ligand binding affinity with applications to molecular docking. Bioinformatics 26(9):1169–1175. https://doi.org/10.1093/bioinformatics/btq112
3. Bera K, Schalper KA, Rimm DL, Velcheti V, Madabhushi A (2019) Diagnosis and precision oncology. Nat Rev Clin Oncol 16(11):703–715. https://doi.org/10.1038/s41571-019-0252-y
4. Bleakley K, Yamanishi Y (2009) Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics 25(18):2397–2403. https://doi.org/10.1093/bioinformatics/btp433
5. Brown D (2007) Unfinished business: target-based drug discovery. Drug Discov Today 12(23–24):1007–1012. https://doi.org/10.1016/j.drudis.2007.10.017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3